DSG3 and pemphigus: To further characterize the two novel DSG1 and DSG1/DSG3 active models, animals were treated with methyl-Prednisolone (m-PSL), a glucocorticoid currently used in the therapy of pemphigus, that was previously used to validate earlier active models.